A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the pain-relieving effects and safety of Tramadol
HCl/acetaminophen as compared to placebo in patients experiencing acute low back pain.
Tramadol HCl/acetaminophen is approved for short-term management of acute pain. The
combination of tramadol HCl/acetaminophen has been shown to be effective for the treatment of
acute musculoskeletal pain. Patients who experienced at least moderate acute low back pain
for 2 to 10 days before study entry will be randomized to receive either tramadol
HCl/acetaminophen or placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.